Bain Capital Life Sciences Investors, LLC — Form 4 insider transactions
Bain Capital Life Sciences Investors, LLC — Full 13F portfolio →
Buys and sells reported on SEC Form 4 — filed within two business days of each trade when a filer's ownership in a stock crosses 10%. This is the fastest public window into what the manager is doing.
| Transaction date | Activity | Security | Shares | Price | Total | Filing |
|---|---|---|---|---|---|---|
| 2026-04-30 | Sell | Heartflow, Inc. | 56,224 | $30.05 | $1,689,531 | SEC filing |
| 2026-04-30 | Sell | Heartflow, Inc. | 892,533 | $29.18 | $26,044,113 | SEC filing |
| 2026-04-29 | Sell | Heartflow, Inc. | 797,133 | $29.37 | $23,411,796 | SEC filing |
| 2026-04-28 | Sell | Heartflow, Inc. | 254,110 | $30.51 | $7,752,896 | SEC filing |
| 2026-04-20 | Buy | Kailera Therapeutics, Inc. | 1,562,500 | $16.00 | $25,000,000 | SEC filing |
| 2026-04-20 | Conversion | Kailera Therapeutics, Inc. | 4,145,768 | — | — | SEC filing |
| 2026-04-20 | Conversion | Kailera Therapeutics, Inc. | 16,875,000 | — | — | SEC filing |
How Form 4 differs from 13F
13F filings are quarterly snapshots, up to 45 days late. Form 4 is transaction-level and lands within two business days — but only covers stocks where the filer reports beneficial ownership above 10%. Pair the two: 13F for the whole portfolio, Form 4 for what the largest holders are doing right now.